Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 16 Sept 2021 for CHIMERIX INC, €31.7M. Read the official filing
Filing timeline
BuySaleCantex Pharmaceuticals, Inc.
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Cantex Pharmaceuticals, Inc.: trading record in brief
Our data holds just one disclosure by Cantex Pharmaceuticals, Inc., dated 16 September 2021, reporting an open-market sale worth €31.7M in Chimerix Inc. Further filings will be added here. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Cantex Pharmaceuticals, Inc.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
6,500,000 shares@ US$5.75100.0% of flowCommon Stock, par value $0.001SEC:0000899243-21-036271:0
1 of 1 declaration
